Futures in Biotech (Audio)

Copyright: © This work is licensed under a Creative Commons License - Attribution-NonCommercial-NoDerivatives 4.0 International - http://creativecommons.org/licenses/by-nc-nd/4.0/

Latest Episodes:

FiB 4: Dr. Marc Vidal, Part 2 Aug 16, 2006

Show notes

Dr. Vidal is working on the next stage in big biotech. Now that we've mapped the human genome it's time to map the interactome, the human protein-protein interaction network. In this episode we talk about the network of interactions, and how closely it mimics other networks, including social networks.

Hosts: Marc Pelletier and Leo Laporte

Guest: Marc Vidal, Ph.D.

Thanks to CacheFly for providing the bandwidth for this podcast.

FiB 3: Dr. Marc Vidal, Part 1 Aug 10, 2006

Show notes

Dr. Vidal is working on the next stage in big biotech. Now that we've mapped the human genome it's time to map the interactome, the human protein-protein interaction network. In this episode he gives us the groundwork for understanding his work. Next week, in part two, Dr. Vidal explains how the network of protein interactions resembles human social networks.

Hosts: Marc Pelletier and Leo Laporte

Guest: Marc Vidal, Ph.D.

Thanks to CacheFly for providing the bandwidth for this podcast.

FiB 2: Dr. Leonard P. Guarente on Aging Jul 21, 2006

Show notes

Why do living things age? What genes influence longevity? Is it possible to extend youthfulness by means of genetic manipulation? What does the aging of a yeast cell have in common with the aging of a human being or a mouse? Dr. Guarente analyzes these tantalizing questions and others in this episode.

Hosts: Marc Pelletier and Leo Laporte

Guest: Dr. Leonard P. Guarente

Thanks to CacheFly for providing the bandwidth for this podcast.

FiB 1: Dr. Susan Lindquist Jun 14, 2006

Show notes

Dr. Susan Lindquist is a member of the Whitehead Institute for Biomedical Sciences at MIT. Her discoveries in protein folding have lead to paradigm shifts in modern genetics and medicine, including how a protein called HSP90 acts as a capacitor modulate evolution, a process that can even be addressed pharmacologically and possibly used as a strategy in some forms of cancer. Her work also contributes to both our understanding of several protein folding diseases such as Parkinson's and Huntington's and seeks to tackle them head on.

Lastly, we discussed her discovery on how to transform yeast prions (similar to the misfolded proteins linked to mad cow disease) into nanowires as used in nanotechnology.

Hosts: Marc Pelletier and Leo Laporte

Guest: Dr. Susan Lindquist

For more information, links, and discussions visit the Futures in Biotech blog.